Global menu

Our global pages

Close
 
Dr. Tobias Maier, Partner

Dr. Tobias Maier

Partner

Rechtsanwalt, Co-head of International Health and Life Sciences

Languages

German, English

Practice areas

  • Health and life sciences
  • Intellectual property
  • International trade
  • Litigation and dispute management
  • Media
  • Technology

Practice notes

Tobias is a Partner in our IP and Commercial practice in Munich and specialises both in contentious and non-contentious aspects of IP law, brand protection, reputation management and media-related work. Furthermore, he is the co-head of the international Health and Life Sciences sector group.

He regularly advises on advertising, trademarks, copyright issues, media rights, anti-counterfeiting, online disputes, defamation and trade secrets.

Tobias' contentious practice includes IP litigation with a focus on preliminary injunction proceedings and the protection and enforcement of the client's IP rights. His non-contentious intellectual property work includes advising clients on all kinds of contracts relating to the creation and exploitation of IP (including technology transfer, licensing, R&D, manufacturing and collaboration agreements). Tobias also handles the IP aspects of all types of major corporate transactions. Tobias is further responsible for the development of strategies for international trade mark portfolios as well as the management and enforcement of national and international trade mark rights before various authorities and regular courts.

He advises national and international companies in the pharmaceutical sector on all aspects of life sciences and pharmaceutical law. Tobias routinely handles clinical trials, licensing, clinical research and CRO agreements for clients from the pharma and life sciences sector. Further, he focuses on regulatory issues and healthcare compliance.

Tobias studied law at the University of Augsburg. During his legal clerkship he worked, inter alia, for the German Society for International Cooperation (Deutsche Gesellschaft für Internationale Zusammenarbeit, GIZ) in the bilateral Sino-German "Legal Advisory Service" in Beijing, People's Republic of China. Thereafter, Tobias wrote a Ph.D. on Chinese unfair competition law at the Max Planck Institute for Intellectual Property and Competition Law in Munich. Prior to joining Eversheds Sutherland Tobias worked with a major US law firm in Munich.

Tobias' recent experience includes advising:

  • Otsuka on its cooperation with Mylan to gain market access and to commercialize a drug fighting multi-resistant tuberculosis in several countries worldwide
  • an international cosmetics company in relation to an international patent and design right infringement case
  • a leading US-American food company on the implementation of advertising clearance strategies
  • a Japanese pharmaceutical company in the area of pharmaceutical compliance and clinical trials as well as non-interventional studies
  • an international pharmaceutical company on the implementation of a compliance system in India, South Africa and Russia
  • an US pharmaceutical company on the conduct of clinical trials in Germany as well as clinical research
  • a famous Italian jewellery company in relation to trademark law infringement by German producer of counterfeiting products
  • an internationally operating brand management and media company for children's and family Entertainment on all media law matters in relation to its blockbuster TV-Series as well as on the acquisition of production shares in such TV-Series from its coproduction partner
  • an international automotive supplier concerning a high-volume cooperation with another automotive supplier in the areas of R&D and licensing
  • a South African generics manufacturer on pharmaceutical advertising and parallel import of pharmaceuticals
  • Chinese solar companies on advertising clearance in conjunction the market entry and presence in Germany
  • a South-African generics manufacturer against a competitor on a litigation case re pharmaceutical advertising (challenging the competitor`s advertising claim for its blockbuster product in the area of thrombosis treatment)

Featured article

An overview on the current German regulatory and liability framework of pharmaceuticals by Dr. Tobias Maier and Magdalena Anna Kotyrba.
View the full article

The Legal 500 - The Clients Guide to Law Firms